Entrada Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 8,910 | $9.98 | $88,922 | 110,026 | Nov 21, 2025 |
| BAKER FELIX | — | Purchase | 1,213 | $9.07 | $11,002 | 380,152 | Nov 20, 2025 |
| PARMAR KUSH | — | Sale | 200,000 | $8.80 | $1,760,000 | 2,963,066 | Nov 14, 2025 |
| 5AM Ventures V, L.P. | — | Sale | 200,000 | $8.80 | $1,760,000 | 2,963,066 | Nov 14, 2025 |
| Baker Bros. Advisors (GP) LLC | — | Purchase | 1,059 | $7.39 | $7,826 | 367,783 | Nov 10, 2025 |
| Doshi Dipal | CEO | Tax Withholding | 8,723 | $5.43 | $47,366 | 415,664 | Sep 2, 2025 |
| Dowden Nathan J | President & COO | Tax Withholding | 1,746 | $5.43 | $9,481 | 179,059 | Sep 2, 2025 |
| Sethuraman Natarajan | President, Research & Develop. | Tax Withholding | 1,760 | $5.43 | $9,557 | 197,899 | Sep 2, 2025 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Tax Withholding | 1,734 | $5.43 | $9,416 | 118,936 | Sep 2, 2025 |
| PARMAR KUSH | — | Sale | 6,935 | $7.50 | $52,013 | 1,093,313 | Jul 9, 2025 |
| 5AM Opportunities I, L.P. | — | Sale | 6,935 | $7.50 | $52,013 | 1,093,313 | Jul 9, 2025 |
| Schwab Andrew J. | — | Sale | 6,422 | $6.81 | $43,734 | 1,106,670 | Jul 1, 2025 |
| PARMAR KUSH | — | Sale | 55,735 | $6.91 | $385,129 | 3,220,287 | Jun 27, 2025 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Option Exercise | 11,134 | $2.10 | $23,381 | 120,670 | Apr 3, 2025 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 1,784 | $10.67 | $19,035 | 109,536 | Mar 17, 2025 |
| Doshi Dipal | CEO | Award / Grant | 116,200 | — | — | 441,953 | Mar 3, 2025 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Award / Grant | 42,400 | — | — | 116,249 | Mar 3, 2025 |
| Sethuraman Natarajan | President, Research & Develop. | Award / Grant | 60,800 | — | — | 205,797 | Mar 3, 2025 |
| Dowden Nathan J | President & COO | Tax Withholding | 5,144 | $11.68 | $60,082 | 180,805 | Mar 1, 2025 |
| MPM BioVentures 2018 GP LLC | — | Sale | 21,787 | $20.23 | $440,751 | 4,381,062 | Dec 10, 2024 |
| MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | — | Sale | 21,787 | $20.23 | $440,751 | 4,381,062 | Dec 10, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Option Exercise | 1,000 | $2.10 | $2,100 | 74,849 | Nov 29, 2024 |
| Sethuraman Natarajan | President, Research & Develop. | Sale | 4,088 | $20.26 | $82,823 | 156,700 | Nov 29, 2024 |
| Sethuraman Natarajan | President, Research & Develop. | Sale | 2,700 | $20.04 | $54,108 | 160,888 | Nov 11, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 8,637 | $19.98 | $172,567 | 73,849 | Nov 11, 2024 |
| Sethuraman Natarajan | President, Research & Develop. | Sale | 5,171 | $18.18 | $94,009 | 177,296 | Nov 4, 2024 |
| Sethuraman Natarajan | President, Research & Develop. | Sale | 600 | $18.00 | $10,800 | 183,216 | Oct 16, 2024 |
| Dowden Nathan J | President & COO | Sale | 847 | $16.00 | $13,552 | 125,149 | Sep 26, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 3,195 | $14.97 | $47,829 | 76,486 | Sep 9, 2024 |
| Sethuraman Natarajan | Chief Scientific Officer | Sale | 600 | $15.24 | $9,144 | 186,458 | Sep 9, 2024 |
| Dowden Nathan J | President & COO | Sale | 1,904 | $15.07 | $28,693 | 125,996 | Sep 6, 2024 |
| Dowden Nathan J | President & COO | Tax Withholding | 483 | $15.76 | $7,612 | 129,624 | Sep 4, 2024 |
| Doshi Dipal | CEO | Tax Withholding | 2,328 | $15.76 | $36,689 | 332,147 | Sep 3, 2024 |
| Sethuraman Natarajan | Chief Scientific Officer | Tax Withholding | 14 | $17.70 | $248 | 188,180 | Sep 3, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Tax Withholding | 14 | $17.70 | $248 | 80,787 | Sep 3, 2024 |
| Dowden Nathan J | President & COO | Sale | 502 | $16.70 | $8,383 | 130,107 | Aug 16, 2024 |
| Sethuraman Natarajan | Chief Scientific Officer | Sale | 638 | $18.00 | $11,484 | 188,814 | Jul 12, 2024 |
| Doshi Dipal | CEO | Sale | 1,600 | $17.81 | $28,496 | 334,475 | Jul 12, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 1,758 | $14.95 | $26,282 | 81,412 | Jul 8, 2024 |
| Doshi Dipal | CEO | Sale | 1,000 | $16.17 | $16,170 | 336,375 | Jun 13, 2024 |
| KIM PETER S | — | Option Exercise | 11,918 | $6.06 | $72,223 | 104,330 | Jun 3, 2024 |
| Sethuraman Natarajan | Chief Scientific Officer | Sale | 9,675 | $15.19 | $146,963 | 190,052 | May 16, 2024 |
| Doshi Dipal | CEO | Sale | 1,200 | $15.11 | $18,132 | 337,375 | May 16, 2024 |
| KIM PETER S | — | Purchase | 25,000 | $14.68 | $367,000 | 92,412 | May 14, 2024 |
| KIM PETER S | — | Purchase | 25,000 | $14.59 | $364,750 | 92,412 | May 14, 2024 |
| KIM PETER S | — | Purchase | 2,276 | $14.04 | $31,955 | 65,212 | May 9, 2024 |
| KIM PETER S | — | Purchase | 2,600 | $13.57 | $35,282 | 62,936 | Apr 8, 2024 |
| KIM PETER S | — | Purchase | 1,512 | $13.75 | $20,790 | 60,336 | Mar 28, 2024 |
| KIM PETER S | — | Purchase | 3,180 | $13.36 | $42,485 | 56,074 | Mar 22, 2024 |
| KIM PETER S | — | Purchase | 1,128 | $12.66 | $14,280 | 49,072 | Mar 21, 2024 |